DGX Estadísticas clave
Alto
233.21
Abrir
228.00
Volumen
1.54M
Bajo
223.42
Cierre anterior
227.90
Valor negociado
353.86M
Máx. 52 sem.
237.78
Volumen rel.
1.414
Amplitud (%)
4.30%
Mín. 52 sem.
165.78
Tasa de rotación
1.39%
Cap. de Mercado
25.14B
PER (TTM)
24.17
PER (Anual)
25.689
P/B
3.35
P/S
2.18
Beneficio por acción (BPA)
9.427
Dividendo (TTM)
3.737
Rentabilidad por dividendo
1.44%
Acciones en circulación
110.69M
Moneda
USD
DGX Rendimiento del Precio
7 día
30 día
90 día
180 día
En lo que va del año
1 Año
DGX Distribución del flujo de dinero
DGX Volumen diario de ventas en corto
DGX Historial de short interest
Resumen de la acción DGX
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17.
On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX cerca de la mitad de its most recent trading range.
Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is por encima de su nivel habitual than usual.
Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
DGX Noticias relacionadas
Acerca de DGX
Nombre empresa
Quest Diagnostics Incorporated
Sector
Health Services
Industria
Services to the Health Industry
Intercambios
NYSE
Número de empleados
57,000
Tamaño del lote
100
Sitio oficial
Moneda
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Related Stocks
DGX FAQ
© 2026 CoinGlass, all rights reserved
